{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:22:49Z","timestamp":1766514169472},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Severe coronavirus disease 2019 pneumonia can lead to acute respiratory distress syndrome. Recently, several publications reported on coronavirus disease 2019-associated pulmonary aspergillosis. However, risk factors remain unclear. We retrospectively collected all the cases of coronavirus disease 2019 acute respiratory distress syndrome patients (<jats:italic toggle=\"yes\">n<\/jats:italic> = 46) admitted to our 34-bed ICU between March 24, 2020, and May 25, 2020, and identified six patients that met the diagnosis of invasive pulmonary aspergillosis according to previously established definitions. This population exhibited higher severity scores at admission and less hospital discharge compared with noninvasive pulmonary aspergillosis patients. Chronic obstructive pulmonary disease, malnutrition, and systemic corticosteroid use were identified as risk factors for invasive pulmonary aspergillosis in coronavirus disease 2019-induced acute respiratory distress syndrome patients. Coronavirus disease 2019-associated pulmonary aspergillosis may be a serious concern regarding corticosteroids use to control the inflammatory response of coronavirus disease 2019-induced acute respiratory distress syndrome.<\/jats:p>","DOI":"10.1097\/cce.0000000000000244","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T20:00:05Z","timestamp":1605124805000},"page":"e0244","source":"Crossref","is-referenced-by-count":25,"title":["Risk Factors for Invasive Pulmonary Aspergillosis in Critically Ill Patients With Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome"],"prefix":"10.1097","volume":"2","author":[{"given":"Paul","family":"Chauvet","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Arras Hospital, Arras, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihad","family":"Mallat","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Critical Care Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clothilde","family":"Arumadura","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Arras Hospital, Arras, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Vangrunderbeek","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Arras Hospital, Arras, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Dupre","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Arras Hospital, Arras, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Pauquet","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Arras Hospital, Arras, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annis","family":"Orfi","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Arras Hospital, Arras, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Granier","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Arras Hospital, Arras, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Lemyze","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Arras Hospital, Arras, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"R1-20231023","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-associated pulmonary aspergillosis.","volume":"202","author":"van Arkel","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20231023","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13054-020-03046-7","article-title":"Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: A retrospective case series","volume":"24","author":"Wang","year":"2020","journal-title":"Crit Care"},{"key":"R3-20231023","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R4-20231023","doi-asserted-by":"crossref","first-page":"e761","DOI":"10.1097\/CCM.0000000000004455","article-title":"Implications of obesity for the management of severe coronavirus disease 2019 pneumonia","volume":"48","author":"Lemyze","year":"2020","journal-title":"Crit Care Med"},{"key":"R5-20231023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20231023","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study.","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R7-20231023","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome.","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R8-20231023","first-page":"296","article-title":"Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans.","volume":"14","author":"Ghanaat","year":"2017","journal-title":"Clin Pract (Lond)"},{"key":"R9-20231023","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","article-title":"The clinical spectrum of pulmonary aspergillosis.","volume":"70","author":"Kosmidis","year":"2015","journal-title":"Thorax"},{"key":"R10-20231023","article-title":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report.","author":"Horby","year":"2020 Jul 17","journal-title":"N Engl J Med"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T17:03:10Z","timestamp":1698080590000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000244","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}